Untitled Quiz
37 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the cardiac index for the patient categorized under Subset I: Warm & Dry?

  • 2.5
  • 3.0
  • 1.5
  • 2.2 (correct)
  • Which patient presentation is most indicative of a Warm & Wet condition?

  • Pulmonary crackles and low O2 saturation
  • Appropriate mentation and warm extremities
  • Cold extremities and confusion
  • Dyspnea with minimal exertion and pitting edema (correct)
  • What would be the appropriate treatment strategy for a patient in Subset III: Cold & Dry?

  • Intensive monitoring without intervention
  • Optimize chronic oral medications (correct)
  • Immediate fluid resuscitation
  • IV loop diuretics plus IV vasodilators
  • Which combination of signs indicates a Cold & Wet condition in a patient?

    <p>Dyspnea and low O2 saturation</p> Signup and view all the answers

    What pulmonary capillary wedge pressure is indicated for Subset II: Warm & Wet?

    <p>18</p> Signup and view all the answers

    What is the primary goal of therapy in patients with acute decompensated heart failure (ADHF)?

    <p>Resolve clinical evidence of congestion and reduce symptoms</p> Signup and view all the answers

    Which of the following is NOT a precaution when using diuretics like furosemide?

    <p>Fluid overload</p> Signup and view all the answers

    How should the dosing of furosemide be adjusted for patients already on home diuretics?

    <p>1 to 2.5 times the daily home dose, given IV</p> Signup and view all the answers

    Which of the following combinations is effective in overcoming diminished diuretic response?

    <p>Metolazone with furosemide</p> Signup and view all the answers

    What is the expected time frame for measurable increase in urine output after diuretic administration?

    <p>Within 2 hours</p> Signup and view all the answers

    How does the duration of action compare between furosemide, bumetanide, and torsemide?

    <p>All three have a similar duration of action of 6 hours</p> Signup and view all the answers

    What is a common result of increasing the dose of loop diuretics?

    <p>A significant increase in urine output</p> Signup and view all the answers

    What is the mechanism by which diminished diuretic response occurs in patients with poor renal function?

    <p>Compensatory sodium reabsorption in distal nephron</p> Signup and view all the answers

    Which hemodynamic condition corresponds to a patient experiencing high pulmonary capillary wedge pressure and low cardiac index?

    <p>Cold &amp; Wet</p> Signup and view all the answers

    What is one of the primary goals of therapy in acute decompensated heart failure (ADHF)?

    <p>Hemodynamic stabilization</p> Signup and view all the answers

    A patient displays symptoms of hypotension and cool extremities. What hemodynamic subset does this likely represent?

    <p>Cold &amp; Wet</p> Signup and view all the answers

    Which diagnostic value is indicative of hypoperfusion in hemodynamic assessment?

    <p>Cardiac index of 1.5 L/min/m2</p> Signup and view all the answers

    What might cause worsening chronic heart failure as a contributing factor to ADHF?

    <p>Medication nonadherence</p> Signup and view all the answers

    In which hemodynamic subset would you find an elevated jugular venous pressure and orthopnea?

    <p>Warm &amp; Wet</p> Signup and view all the answers

    What is the typical range for cardiac output in a healthy individual?

    <p>4-6 L/min</p> Signup and view all the answers

    What pharmacotherapy-related plan is commonly developed for managing a patient with ADHF?

    <p>Diuretic therapy plan</p> Signup and view all the answers

    Which condition is a possible new cardiac process leading to acute decompensated heart failure?

    <p>Hypertensive crisis</p> Signup and view all the answers

    What laboratory value defines a normal pulmonary capillary wedge pressure?

    <p>12 mmHg</p> Signup and view all the answers

    What is the recommended initial dose of continuous infusion for a venodilator?

    <p>5 – 10 mcg/min</p> Signup and view all the answers

    Which diuretic is NOT mentioned as an option for a patient with a shortage of furosemide?

    <p>Hydrochlorothiazide</p> Signup and view all the answers

    Which subset indicates a patient with adequate cardiac output but presenting with fluid overload?

    <p>Subset II</p> Signup and view all the answers

    Which vasodilator is more likely to cause cyanide toxicity at high infusion rates?

    <p>Nitroprusside</p> Signup and view all the answers

    What is a common risk associated with using inotropes in treating heart failure?

    <p>Hypotension</p> Signup and view all the answers

    What condition does vasopressin antagonism primarily aim to improve in patients with heart failure?

    <p>Serum sodium levels</p> Signup and view all the answers

    In what clinical situation is nitroglycerin preferred for therapy?

    <p>Pulmonary congestion with acute coronary syndrome</p> Signup and view all the answers

    What can be a consequence of prolonged infusions of nitroprusside?

    <p>Thiocyanate toxicity</p> Signup and view all the answers

    What is the maximum dose of nitroglycerin infusion recommended?

    <p>200 mcg/min</p> Signup and view all the answers

    Which medication primarily antagonizes vasopressin receptors for treatment of hyponatremia?

    <p>Conivaptan</p> Signup and view all the answers

    What condition is usually associated with hypervolemic hyponatremia in heart failure?

    <p>Elevated AVP levels</p> Signup and view all the answers

    What is the primary goal of therapy in heart failure treatment?

    <p>Improve cardiac output</p> Signup and view all the answers

    What should be assessed before administering intravenous diuretics?

    <p>Volume status</p> Signup and view all the answers

    Which patient condition corresponds to a high pulmonary capillary wedge pressure and low cardiac output?

    <p>Subset IV</p> Signup and view all the answers

    Study Notes

    Acute Decompensated Heart Failure

    • ADHF is a clinical syndrome resulting from the heart's inability to effectively pump blood, often characterized by volume overload and/or low cardiac output.
    • Key goals in ADHF therapy include hemodynamic stabilization, symptom relief, and prevention of immediate morbidity and mortality.

    Causes of ADHF

    • ADHF can be caused by worsening chronic heart failure, a new or worsening cardiac process, or de novo heart failure.
    • Contributing factors to ADHF include non-adherence to therapies, medications that increase sodium retention, medications that have a negative inotropic effect, dietary indiscretion, uncontrolled hypertension, substance abuse, and concurrent non-cardiac illness.
    • New or worsening cardiac processes that can lead to ADHF include acute coronary syndrome (ACS)/myocardial infarction (MI), atrial fibrillation/other arrhythmias, and hypertensive crisis.

    Hemodynamic Subsets in ADHF

    • ADHF can be categorized into four hemodynamic subsets based on volume status (wet or dry) and perfusion status (warm or cold).
    • Each subtype is characterized by specific clinical findings and requires tailored treatment strategies.

    Hemodynamic Parameters in ADHF

    • Volume (Wet):
      • Pulmonary congestion
      • Edema
      • Elevated jugular venous pressure
      • Fluid overload
      • Dyspnea
      • Orthopnea
      • Weight gain
      • Ascites
    • Perfusion (Cold):
      • Hypotension
      • Cool extremities
      • Pallor
      • Altered mental status
      • Oliguria
      • Nausea and Vomiting
      • Impaired end-organ perfusion
    • Key Hemodynamic Parameters:
      • Volume/Preload
        • Central venous pressure (CVP)
        • Pulmonary capillary wedge pressure (PCWP)
      • Pressure
        • Systemic arterial pressure (BP)
        • Mean arterial pressure (MAP)
        • Pulmonary artery pressure (PAP)
        • Systemic vascular resistance (SVR)
      • Output
        • Cardiac output (CO)
        • Cardiac index (CI)

    Subset Classification Chart

    • Subset I: Warm & Dry
      • Characterized by: No signs of congestion (dry) and adequate perfusion (warm).
      • CI > 2.2
      • PCWP ≤ 18 mmHg
    • Subset II: Warm & Wet
      • Characterized by: Volume overload (wet) and adequate perfusion (warm).
      • CI > 2.2
      • PCWP > 18 mmHg
    • Subset III: Cold & Dry
      • Characterized by: Inadequate perfusion (cold) and absence of volume overload (dry).
      • CI < 2.2
      • PCWP ≤ 18 mmHg
    • Subset IV: Cold & Wet
      • Characterized by: Inadequate perfusion (cold) and volume overload (wet).
      • CI < 2.2
      • PCWP > 18 mmHg

    Pharmacotherapy Treatment Plan for ADHF

    • Initial Management:
      • Optimize chronic medications for heart failure
    • Diuretic Therapy
      • IV loop diuretics are the cornerstone for addressing fluid overload and congestion
      • Common options include furosemide, bumetanide, and torsemide
      • Dosing is typically based on patient's response to previous oral doses
      • Continuous infusions may be employed for refractory fluid overload
    • Vasodilator Therapy:
      • Nitroglycerin:
        • Venodilator, primarily for preload reduction
        • Can also provide coronary vasodilation for patients with ACS.
      • Nitroprusside:
        • Both venodilator and arterial vasodilator
        • Can induce more pronounced decreases in SVR and systemic blood pressure.
    • Inotropic Therapy:
      • Dobutamine:
        • Primary use is to improve cardiac output and reverse end-organ abnormalities
        • Can lead to hypotension, sinus tachycardia, arrhythmias, and increased in-hospital mortality.
      • Considerations:
        • Inotropic agents should be used with caution due to the risk of adverse effects.
        • Inotropes should be reserved for patients with low blood pressure and who are not responding to diuretics and vasodilator therapy.

    Additional Considerations:

    • Treatment Strategy for Low Blood Pressure:

      • Assess volume status (PCWP)
      • Use IV fluids for hypovolemia (PCWP ≤ 15)
      • For euvolemia (PCWP 15-18 mmHg), monitor blood pressure
      • If SBP remains below 90 mmHg, consider inotropic therapy (and potentially vasopressors if necessary)
      • If BP ≥ 90 mmHg and no improvement is observed, consider vasodilator therapy.
    • Treatment Strategy for High Blood Pressure:

      • Assess BP
      • If < 90 mmHg, consider inotropes (and potentially vasopressors if needed) with IV diuretics.
      • If ≥ 90 mmHg, use IV diuretics and consider adding a vasodilator.
    • Role of Vasopressin Receptor Antagonists

      • Conivaptan and tolvaptan are vasopressin antagonists that may help with water retention.
      • They block the action of vasopressin at the collecting duct, promoting water excretion.
      • Primary use is for ADHF with hyponatremia, although they may not improve clinical outcomes.
    • Diuretic Management

      • Diuretic therapy should be tailored based on patient's response and clinical status.
      • Urine output should increase within 2 hours of diuretic administration.
      • Significant dose increases may be necessary due to the logarithmic dose-response curve.
      • Increases in serum creatinine (up to 0.5 mg/dL) are common and do not always necessitate stopping loop diuretics.
      • Combination therapy can improve diuresis but increase risk of electrolyte abnormalities.
    • Electrolyte Abnormalities:

      • ADHF commonly leads to hypervolemic hyponatremia.
      • The use of diuretics and vasodilators necessitates close electrolyte monitoring and management.
    • Key Facts

      • Vasodilators can be used for patients with high blood pressure.
      • Nitroglycerin is primarily a venodilator and can be used for coronary vasodilation.
      • Nitroprusside can cause cyanide and thiocyanate toxicity, but only if the patient has renal failure or the infusion is prolonged.
      • Inotropic agents are used to improve cardiac output but may increase mortality.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Heart Failure HANDOUT 2024 PDF

    More Like This

    Untitled Quiz
    6 questions

    Untitled Quiz

    AdoredHealing avatar
    AdoredHealing
    Untitled Quiz
    37 questions

    Untitled Quiz

    WellReceivedSquirrel7948 avatar
    WellReceivedSquirrel7948
    Untitled Quiz
    55 questions

    Untitled Quiz

    StatuesquePrimrose avatar
    StatuesquePrimrose
    Untitled Quiz
    18 questions

    Untitled Quiz

    RighteousIguana avatar
    RighteousIguana
    Use Quizgecko on...
    Browser
    Browser